期刊文献+

基质金属蛋白酶7在中老年胆管癌组织中的表达及其临床意义 被引量:2

Expression and clinical significance of metrix metalloproteinases 7 in bile duct carcinoma
下载PDF
导出
摘要 目的 探讨中老年胆管癌患者癌组织中基质金属蛋白酶 7(MMP- 7)的表达与临床病理参数和预后的关系。方法 采用 S- P法进行MMP- 7的免疫组化染色。结果  MMP- 7的表达阳性率为 92 %。MMP- 7在胆管癌的表达情况与胆管癌的病理分型和黄疸程度无关 ,与原发部位、分化程度、浸润深度、神经浸润程度及临床分期有关。结论  MMP- 7在胆管癌中的表达情况与胆管癌的一些临床病理参数有关 ,提示 MMP- 7是估价胆管癌预后的良好标志物。 Objective To investigate the correlation between the expression of matrix metalloproteinases 7 (MMP-7) and clinicopathologic parameter in bile duct carcinoma (BDC); to evaluate the potential prognostic value. Methods The expression of MMP-7 in 8 subjects with normal common bile ducts, 4 subjects of congenital choledochal cyst and 25 subjects of BDC were detected by immunochemical staining (S-P method). Results 37 subjects exhibited MMP-7 positive expression (92%), correlated with location, histological grade, infiltration grade,perineural invasion grade and clinical stage, incorrelated with pathology type and severity of jaundice. Conclusions The expression of MMP-7 was correlated with some clinicopathologic parameters of BDC, and MMP-7 was a valuable prognostic marker of BDC.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2004年第2期108-110,共3页 Chinese Journal of Gerontology
关键词 基质金属蛋白酶7 中老年 胆管癌 预后 癌组织 病理分型 Bile duct carcinoma (BDC) Immuneohistochemistry method MMP-7
  • 相关文献

参考文献5

二级参考文献36

共引文献77

同被引文献34

  • 1Kawin Leelawat,Siriluck Narong,Jerasak Wannaprasert,Thawee Ratanashu-ek.Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma[J].World Journal of Gastroenterology,2010,16(37):4697-4703. 被引量:8
  • 2王新保,彭淑牖,郭剑民,李江涛,张则伟,程向东,杜义安.胆囊癌病人基质金属蛋白酶-7的表达[J].中华肝胆外科杂志,2006,12(1):64-65. 被引量:2
  • 3LIOTTA LA.Tumor invasion and metastaees-role of the extracellularmatrix:Rhoads Memorial Award lecture[J].Cancer Res,1986,46(1):1.
  • 4CLENDENINN NJ,APPELT K.Matrix metalloproteinase inhibitors in cancer therapy[M].Totowa:Humana Press Inc,2001:1.
  • 5VAN KEMPEN LC,RHEE JS,DEHNEK,et al.Epithelial carcinogenesis:dynamicinter play between neoplastic cell sandtheirmicro environment[J].Differentiation,2002,70:610.
  • 6LYNCH CC,MATRISIAN LM.Matrix metalloprotemases in tumor hostcell communication[J].Differentiation,2002,70:561.
  • 7THOMAS K,RONAL V.Guidebook to the extracellular matrix,anchor,and anhesion proteins[M].Ed 2.New York:Oxford University Press Inc,1999:505.
  • 8COX G,O' bYRNE KJ.Matrix metalloproteinase and cancer[J].Anticancer Res,2001,21 (6B):4207.
  • 9LIZASA T,FUJISAWA T,SUZUKI M.Elevated levels of circulating plasma matrix metalloproteinase-9 in non-small cell lung cancer patients[J].Clin Cancer Res,1999,5 (1):149.
  • 10SHALINSKY Dr.BREKKEN J,ZOU H.Marked antiangio genic and antium or efficacy of AG 3340 in chem.Oresistant human non-small cell lung cancer turnours single agent and combination therapy studies[J].Clin Cancer Res,1999,5(7):1905.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部